XenoPort to Present at Upcoming Healthcare Conferences – Business Wire (press release)

by admin on February 20, 2013

XenoPort to Present at Upcoming Healthcare Conferences
Business Wire (press release)
Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved in the United States for the treatment of moderate-to-severe primary restless legs syndrome (RLS) in adults and for the management of postherpetic neuralgia in adults

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: